US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Obstetrics/Gynecology Market Research Reports & Industry Analysis

RSS Feeds

Obstetrics/Gynecology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
2015 Market Research Report on Global Menstrual Cups Industry
2/1/2015 | published by: QYResearch Group
... application, industry chain structure, industry overview, policy analysis, and news analysis, etc For international and China market analysis, the report analyzes Menstrual Cups markets in China and other countries or regions (such as US, Europe, ...  |  read more...
USD 2,600
Vulvovaginal Candidiasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Vulvovaginal Candidiasis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... pipeline drugs and marketed drugs across the Hormone Replacement Therapy (HRT). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different ...  |  read more...
USD 2,000
Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Metastatic Ovarian Cancer. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Global In Vitro Fertilization (IVF) & Male and Female Fertility treatment market, Industry Overview, Intra cytoplasmic sperm injection, IVF market, Materials & Chemicals, Medical Devices, Protein Purification, Gene Expression, DNA & RNA , Pharmaceuticals,
1/20/2015 | published by: Occams Business Research & Consultancy
... Analytical Reagents Market and Technology, Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Segmentation and Forecast 2014 - 2020 Infertility, in the 21st century, is a global issue with thousands of couples facing ...  |  read more...
USD 4,000
Endometriosis - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Polycystic Ovarian Syndrome - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Premenstrual Syndrome - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... therapeutic development for Premenstrual Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Women Infertility-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Women Infertility. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Chlamydia Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Chlamydia Infections. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Endometriosis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Endometriosis. ...  |  read more...
USD 2,000
Vaginal Atrophy (Atrophic Vaginitis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... pipeline drugs and marketed drugs across the Vaginal Atrophy (Atrophic Vaginitis). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different ...  |  read more...
USD 2,000
Vulval Atrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Vulval Atrophy. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Cervical Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Cervical Cancer. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dysmenorrhea. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dysmenorrhea. ...  |  read more...
USD 2,000
Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Female Sexual Dysfunction. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Post Menopausal Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Post Menopausal Osteoporosis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Global Cervical Cancer Diagnostic Tests Industry 2014 Market Research Report
1/20/2015 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cervical Cancer Diagnostic Tests basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 2,850
Bacterial Vaginosis - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... therapeutic development for Bacterial Vaginosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Amenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Amenorrhea. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Amenorrhea. ...  |  read more...
USD 2,000
Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014
12/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Trichomonas Vaginitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Cervical Dysplasia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Cervical Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)
1/1/2015 | published by: Daedal Research
... CHC market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses key opportunities in the market and outlines the factors that are and will ...  |  read more...
USD 800
Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... - 2015’. The report provides insights into Ovarian Cancer epidemiology, Ovarian Cancer diagnosed patients, and Ovarian Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Ovarian Cancer ...  |  read more...
USD 1,200
< prev 1    3  4  5  6  7  8  9  10